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ABSTRACT
Currently, TLDs and Gafchromic EBT3 film are commonly used for skin dose
measurement during Total Skin Electron Therapy (TSET). However, measurements using
these dosimeters is very time consuming due to post-irradiation processing requirements.
Also, accurate skin dose measurements are challenging with these dosimeters since the
radiosensitive layer of the skin sits at an approximate depth of 0.07mm. The MOSkin
detector has advantages of being of a small physical size and submicron dosimetric
volume and a water equivalent depth of 0.07mm while providing real-time dosimetry.
Measurements of the MOSkin’s dosimetric characteristics were performed using
a 6 MeV electron beam with an Elekta Infinity linear accelerator at the Prince of Wales
Hospital. For the TSET measurements, doses measured with the MOSkin detector were
directly compared to TLDs and Gafchromic EBT3 film using a 6 MeV high dose rate
electron (HDRE) beam. A 6 mm Perspex spoiler was placed and aligned perpendicularly
to the beam in order to lower the effective beam energy and improve dose homogeneity.
MOSkin dose response was observed to be effectively linear over 3 Gy of the total
dose. The response of the MOSkin showed the expected increase in surface dose with
incident beam angle. For dose rate response, the effect on the MOSkin’s measurements
was not significant. For the TSET measurements, all three detector types showed a very
similar trend of dose readings over every measurement points.
The MOSkin is an effective skin dosimeter for TSET dosimetry as it provides
stable skin dose readings that compared acceptably with the TLD and EBT3 film results.
It also showed good dose linearity and dose rate independence for 6 MeV electron beam
and behaved very similarly to the other types of dosimeters that are commonly used for
TSET in vivo dosimetry.
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1. INTRODUCTION
Skin dose measurement can be important during radiation therapy to verify the
delivery of a prescribed dose to the targeted cutaneous area. A dosimetric technique used
to assess the dose to the skin surface and underlying tissue is called in vivo skin dosimetry.
In vivo dosimetry can be used at points all over a patient’s body particularly for patients
receiving total body irradiation (TBI) or total skin electron therapy (TSET).
Traditionally, thermoluminescent dosimeters (TLDs) and film have been used
most commonly for in vivo dosimetry on TSET because, compared to other types of
dosimeters, they are cheap, can be prepared into various sizes and point doses can be
measured across multiple areas of a patient’s body at the same time. Also, no external
voltage supply is required and therefore no cables are attached when operating them.
However, measurement using these dosimeters is very time consuming due to pre- and
post-irradiation processing requirements. Also, accurate skin dose measurements are
challenging with these dosimeters since the radiosensitive layer of the skin, called basal
cell layer, sits at an approximate depth of 0.07mm (5). An ideal in vivo skin dosimeter
should be tissue equivalent, small in physical size with a thin water equivalent depth
(WED) to measure the dose at the basal cell layer level, consistent with factors such as
temperature and energy (6). Also, it should not disturb the radiation field, be safe to use
directly on a patient’s skin, angular independent, and provide a real-time dose reading for
fast and accurate skin dose reading (6).
The MOSkin detector could be a good alternative to traditional in vivo skin
dosimeters for TSET. It has advantages of being of a small physical size and submicron
dosimetric volume and a water equivalent depth of 0.07mm while providing real-time
dosimetry. MOSkin detectors have previously been investigated as dosimeters in external
beam radiation therapy and brachytherapy and subsequently has been characterised for
1

megavoltage and kilovoltage photon beams. However, application and characterisation
of the MOSkin detector for megavoltage electron beam therapy have not been studied and
therefore the aims of this project are
•

Characterisation of MOSkin detector in 6 MeV electron beam (the only beam
energy setting used for TSET at the Prince of Wales Hospital)

•

Comparing the dose readings with TLD and Gafchromic EBT3 film under TSET
treatment conditions using the high dose rate 6 MeV electron beam
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2. LITERATURE REVIEW
2.1 Electron beam therapy
Electron beam therapy is a type of external beam radiation therapy used for the
treatment of tumours at shallow depth. The electron beam has a property of limited
penetration range and rapid dose fall off and so it is useful for skin cancer, electron boost
for breast cancer and nodes (7). Electron beams can provide a uniform distribution of the
dose to the target volumes at a specific depth while providing the optimum tissue sparing
effect for the deeper tissue (7, 8).
In the late 1930s, Van de Graaff and Trump developed the first electron beam
radiotherapy machine called the Van de Graaff accelerator (9, 10). It generated electron
beams with an energy less than 3 MeV and therefore was only used for treating surface
lesions (9). Then, in the late 1940s, a machine called a Betatron was developed and used
for accelerating electrons with an energy up to tens of MeV (11). High energy electron
beam radiation therapy has been performed since the early 1950s (8, 12). Initially, the
therapeutic application of a 6 MeV betatron was first performed by Gund and Paul in
Germany in 1950 (13). Then the modern high energy linear accelerator (linac), with the
capability of producing both photon and electron beams became more commonly used (8,
12). In the early 1980s, the electron pencil beam algorithms were developed and
implemented for dose calculation.
An electron is a charged particle with very small mass of approximately 9.11 x
10-31 kg. When it enters a medium, it undergoes multiple interactions with atoms within
the medium which results in direct energy loss or scattering or a combination of both in
random directions (1). This random process limits the energy distribution range and
therefore results in a sharp dose fall at shallow depth as appeared on figure 1. The depth
where the absorbed dose reaches the maximum (dmax) increases with energy. At lower
3

energies up to 20 MeV, an electron beam delivers 90 to 100 % of maximum dose up to 6
cm depth and the dose falls off rapidly with depth so that it allows to spare the underlying
tissues (9). However, as the beam energy increases, depth dose curves of electron beams
lose their property of rapid dose fall off and the photon contamination appears due to
increased Bremsstrahlung production (9). Thus, electron beams with the energies in the
range of 6 to 20 MeV are normally used for treating shallow tumours (9). Clinically,
electron beam therapy is typically performed for treating skin and lip cancers, postsurgery or recurrent cancer on chest wall and neck, upper respiratory and digestive tract
lesions within 6 cm in depth, and boost treatment to the tumour bed after mastectomy or
lumpectomy (9).
120
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Figure 1. Central axis percentage depth dose (PDD) curves of electron beams with various energies at 100
cm SSD using a 10 cm x 10 cm applicator. Beam data obtained from Elekta Infinity linear accelerator at
the Department of Radiation Oncology at the Prince of Wales Hospital.
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2.2 Electron beam production and delivery
In linear accelerator, the electron beam is originated from the electron gun. An
electron gun consists of a cathode and an anode. The cathode is a tungsten filament which
releases electrons when heated. Electrons are then attracted towards the perforated anode
and being focused as they are passing through the hole in the anode (4). They are then
injected into the bunching section of the accelerating waveguide and electrons bunches
are then accelerated close to the speed of light by radio frequency (RF) pulsed
microwaves while travelling along the waveguide tube (1). The RF microwaves are
generated by either a magnetron or a klystron and have a frequency of about 3GHz (1, 4).
The choice of the type of RF microwave generator is depending on the design
requirements and manufacturer’s preference. After being accelerated, the pulsed electron
beam is bent toward the patient and refocused by the bending magnets. In general, either
a 270 degree or a 112.5 degree (also known as slalom system) bending magnet system is
used for linear accelerator depending on the design requirements and manufacturer’s
preference. After passing the exit window, the electron beam has a diameter of a few
millimetres, and therefore a scattering foil is necessary to spread out the beam for clinical
use (1, 4). Electron applicators with levels of collimation planes are used to achieve a
relatively well defined edge of the electron beam (4).

2.3 Electron interactions with matter
When electrons in the energy range used in electron therapy enter material, they
transfer their energy continuously via many interactions with atoms along their trajectory.
So, the energy of electron beam decreases with the depth in tissue (4). The most important
electron interactions include collisions with orbital electrons and coulombic interaction
with the nuclei of atoms (1, 4).
5

Collisions are of major interest since these events result in direct energy
deposition within the medium and the probability of collisional energy loss depends on
the energy of the incident electron and the atomic number of the medium (1, 4).
Collisional energy loss occurs when a fast moving electron approaches close enough to
remove an atomic electron from its orbiting shell temporarily or permanently (4). If the
incident electron is temporarily removed from its orbiting shell, the electron is
temporarily elevated to a higher energy level and so the atomic electron becomes excited.
Then the emission of a visible light photon occurs when the temporarily excited electron
goes back to the lower energy level.

Figure 2. Electron interaction process: Excitation. (Adapted from (1))

If the incident electron has greater energy than the binding energy of an orbiting
electron and permanently removes an orbiting electron of an atom, the atom becomes
ionised (1, 4).

6

Figure 3. Electron interaction process: Ionisation. (Adapted from (1))

Radiative energy loss occurs when the incident electron interacts with the nucleus
of an atom and the probability of such energy loss depends on how closely the incident
electron approaches the nucleus. The probability increases if the distance between the
approaching electron and the nucleus of the atom decreases (1, 4). When the incident
electron approaches closely to the nucleus of an atom, it will experience nuclear Coulomb
force and be deflected from its trajectory and loses its energy as a form of electromagnetic
radiation so-called Bremsstrahlung radiation as appeared on figure 4 (1, 4). This process
is called radiative energy loss as the kinetic energy of the incident electron is converted
to a form of electromagnetic radiation (4).

7

Figure 4. Electron interaction process: Bremsstrahlung production. (Adapted from (1))

The emission of characteristic K radiation also occurs if ionisation occurs in the
K-shell of the atom (1). After the removal of the K-shell electron, a vacancy is created
and an electron from L or M shell fills this vacancy and the energy difference between
the binding energies of inner and outer shells is emitted as a form of electromagnetic
radiation so called the characteristic K-radiation (1).

Figure 5. Electron interaction process: Characteristic radiation production. (Adapted from (1))
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2.4 Total skin electron therapy
Total Skin Electron Therapy (TSET) is a type of electron beam therapy that was
first introduced in the 1950s to treat mycosis fungoides (MF) (14). MF is a type of
cutaneous T-cell lymphoma (CTCL) which is a lymphoproliferative disorder
characterised by localisation of malignant T lymphocytes to the skin and to the T-cell
zones of lymphoid structures (15, 16). MF is the most common type of CTCL and it
accounts 80 to 85% cases of CTCL (15). It was first described by Alibert in 1806 and the
term ‘mycosis fungoides’ was used due to its mushroom-like tumour shape. MF is
classified into three different stages; patch stage, plaque stage, and tumour stage
depending on the clinical appearance (17). It is hard to cure and treatment is usually
palliative to relieve symptoms and improve the quality of life. However, patients
diagnosed in early stage have significant longer term survival (18).

Figure 6. Different stages of mycosis fungoides (MF). Pictures reproduced with permission from DermNet
New Zealand (2)

Several treatment options are available depending on the stage of the disease. For
patients with patch or plaque stage MF generally receive skin-directed therapies using
corticosteroids or topical chemotherapy (19). Systemic therapies are the option for
advanced stage disease or for patients who do not respond to skin directed therapies (19).
Radiotherapy is an effective treatment option for treating MF because the malignant T
9

lymphocytes are the most radiosensitive of all cells (20). Radiotherapy can be delivered
either locally (in unilesional or oligolesional disease) or entirely on patient’s skin area
with palliative or curative purpose (19).
TSET aims to deliver a uniform prescribed dose to the entire patient’s skin surface
to a specified depth (21). Several irradiation techniques are used and the three most
commonly are: six static dual-field technique, eight static dual-field technique, and
rotational technique. The six static dual-field technique also known as the Stanford
technique was introduced by Page et al. at Stanford University in 1970 (3, 22). It is the
most widely used technique and, as the name suggests, this treatment technique involves
six angular orientations (60 degree intervals as shown on figure 7). The patient stances
for each angle are appeared on figure 8. The TSET dose is delivered in two fields (superior
and inferior) at each angle while the patient is standing to provide sufficient dose
uniformity over the patient’s height and width (3).

Figure 7. The angular orientation of the six static dual-field technique
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Figure 8. Six patient stances: (Clockwise from top left) left anterior oblique, anterior, right anterior oblique,
right posterior oblique, posterior, left posterior oblique. Pictures reproduced with permission from AAPM
Report No. 23 (3)

However, studies have found that the six dual-field technique provides
considerably less dose uniformity than the eight dual-field and the rotational techniques
due to the body curvatures, varied angles of incident electrons, and a finite number of
patient orientations (3). The human body is not cylindrical and therefore there are some
shaded areas where the dose received is lower than other parts of the body (3). According
to AAPM Report 23, the rotational technique provides the best dose uniformity and the
eight dual-field technique provides almost the same (3). During rotational irradiation, the
patient stands on a rotating platform and the TSET dose is delivered in two fields with
gantry angles of 90 ± 18º while the patient is rotating (23). It is also advantageous for
reducing the treatment time so that the patient does not need to hold the required positions
for long time (24).
11

Figure 9. The angular orientation of the eight static dual-field technique

Modern linear accelerators offer high dose rate (HDR) electron beam option to
deliver 1000 or more monitor units (MU) per minute. This option is useful for reducing
the treatment time as TSET treatment involves multiple orientations and the patient needs
to hold the required stances while irradiating each orientation. TSET is performed using
electron beams with nominal energies of 4 to 10 MeV at the linear accelerator, also called
a linac, exit window(3). The mean beam energy then decreases as the beam passes from
the exit window to the treatment plane (3). A thin scatterer, also known as a spoiler, is
placed in front of the treatment plane when performing TSET treatments to reduce the
electron beam energy to a desired level (3 to 7 MeV at the patient’s skin) and to improve
electron uniformity (3, 4). The spoiler causes the incident electrons to scatter before
reaching the treatment plane to further spread out the electrons and improve dose
uniformity.
The most probable energy at the phantom surface can be obtained from the rangeenergy relationship:
𝐸𝑝,0 = 1.95 𝑅𝑝 + 0.48 MeV

12

(1)

where Rp is the practical range in cm in water (25). The mean electron energy at the
surface of the phantom can be calculated by,
𝐸0 = 2.33 𝑅50 MeV

(2)

where, R50 is the depth of half maximum dose in cm in water (3, 25).
At Prince of Wales Hospital, TSET is performed using a 6 MeV high dose rate
electron (HDRE) beam. A rotational irradiation technique is used and the dose is
delivered in two beams at gantry angles of 252º and 288º for upper and lower body while
the patient is rotating at a speed of 25.8 seconds per rotation. A 6 mm Perspex spoiler is
used and aligned perpendicularly to the beam in order to lower the effective beam energy
and improve dose homogeneity. The R50 and Rp calculated from the PDD curve of 6 MeV
HDRE beam under TSET treatment conditions with a 6 mm spoiler, appeared on figure
22, are 12.3 mm and 20.8 mm respectively. So, the E0 and Ep,0 at the surface of the
phantom are approximately 2.9 MeV and 4.5 MeV respectively.

2.5 Radiation detectors used for surface dosimetry
2.5.1 Thermoluminescent dosimeters
Thermoluminescent dosimetry (TLD) is one of the most widely used technique
for in vivo dosimetry for many types of external beam radiotherapy and brachytherapy,
and it was first used for ionising radiation almost 100 years ago (26-28). A variety of TL
detectors are available for TLDs including capsule type (TL powder encapsulated in a
capsule), carbon loaded LiF disks, LiF:Mg,Cu,P chips and so on (4). Among those, the
most commonly used TL detector for in vivo dosimetry is TLD-100 (LiF:Mg,Ti) (4, 29).
TL detectors have advantages of being in small size, reusable, and no cables required (4,
29). They are used for point dose measurements and can be directly attached to the
13

patient’s skin for in vivo dosimetry. It is regarded as a gold standard for in vivo dosimetry
and provides the best results with the tolerance range of ± 10 % for TSET (30-35).
TLDs are non-conducting in general and all electrons are within the valence band
in energy band model at room temperature (4). A number of imperfections such as
Magnesium (Mg), Titanium (Ti), Copper (Cu), Phosphorus (P) are added to the crystal
and sit within the energy gap between the conduction and valence bands. When the crystal
is irradiated by ionising radiation, some electrons gain enough energy to move up to the
conduction band (excitation). After the irradiation, these electrons return back to
equilibrium state (relaxation) to the valence band, however, approximately 1% of the
electrons are trapped by the imperfections (metastable state) (4, 36). The number of
electrons trapped by the imperfections is proportional to the intensity of the incident
radiation (4). Excitation of these trapped electrons occurs with external heat so that the
escaped electrons move up to the conduction band. These electrons then lose their energy
as a form of visible light and fall back to the valence band. The light signal is then
registered by a photomultiplier tube (PMT) and the amount of emitted light is proportional
to the absorbed dose (4, 29). Thermal annealing process must be performed to remove
residual signals every time before use (29).
There are factors affecting the TLD dose readings. Supra-linearity of TLDs occurs
when measuring doses higher than 1 Gy. The concentration of titanium (Ti) affects the
supralinear response of TLDs. Higher Ti concentration shifts the onset of supralinear
response to higher doses (4). Supra-linearity can also be affected by the glow curve peak.
Higher glow peak number can cause the onset of supralinear response at lower doses (4).
Annealing temperatures and the cool down rate can also affect supra-linearity of TL
material (4, 36). The energy dependence of the TLDs should be considered as the dose
response varies with the beam quality and also influences supra-linearity response (4, 29).
14

If TLDs are calibrated in a Co-60 photon beam, corrections for energy dependence can
be made by multiplying factors of 1.01 and 1.025 by the doses measured with 6 MV and
25 MV photon beams respectively and factors of 1.04 and 1.03 by the doses measured
with 2 MeV and 20 MeV electron beams respectively (37-39). However, according to the
International Atomic Energy Agency (IAEA) Human Health Reports No. 8, it is simpler
to calibrate TLDs against an ionisation chamber in the same beam energy as used for the
measurements (37). Fading can result in a reduction of TL signal. After irradiation, the
electrons trapped in imperfections gain energy at room temperature and escape out with
the emission of light. So, the TL signal decreases with time. The probability of fading is
inversely proportional to the difference between the conduction and valence bands, also
known as the energy gap (4, 29). That is, narrower the energy gap higher the probability
of fading. This effect could be minimised if all TLD readings are performed with the same
time delay after the irradiation (29). TLDs are also time consuming as it requires
calibrations for each TL dosimeter to provide accurate dose reading.

2.5.2 Radiochromic film
Radiochromic film has many advantages over radiographic film. It is almost
completely energy independent for x-ray beams over a therapeutic range from 6 MV to
15 MV, and electron beams over a therapeutic range from 6 to 22 MeV (40, 41). It is
flexible, almost completely tissue equivalent and provides high two-dimensional (2D)
spatial resolution and can be prepared in various shapes and sizes which make the film a
favourable tool for measuring skin dose. Also, unlike radiographic film, no chemical
processing is required after irradiation due to its self-developing capability and therefore
eliminates processing discrepancies (4). The active layer of radiochromic film contains
diacetylenes which turns blue or red through a polymerisation process upon irradiation
15

(29, 42, 43). In particular, Gafchromic EBT films use the lithium salt of pentacosa-10,12diynoic acid (LiPCDA) which allows the films can be used at doses as low as 1 cGy (44,
45). Gafchromic EBT3 film consists of a 28 µm thick active layer sandwiched between
two, 125 µm thick, polyester layers (42). Optical densitometry is used to assess changes
in colour quantitatively by using a densitometer (4). Within the densitometer, the optical
density (OD) can be calculated from the ratio between the intensity of light emitted from
the light source from one side of the film, Φ0, and the transmitted light detected from the
other side of the film, Φ (4). Optical density is calculated by:

OD = 𝑙𝑜𝑔10 (

Φ0
)
Φ

(3)

According to the EBT3 vendor specification and user guide provided by Ashland
Inc., a 48-bit (16-bit per channel) flatbed colour scanner is recommended for EBT3 film
dosimetry (42). EBT film exhibits orientation dependence and variations in net OD were
found approximately 15%, and 4% at the dose levels of 50 cGy and 3 Gy respectively
(46). This occurs because the film consists of various layers and therefore its construction
causes the light scattering effect (polarisation) with varying rotational reference when
scanning (46). So, it is essential to scan EBT3 film with the same orientation every time
when performing film dosimetry (29). The scanner’s flatbed surface needs to be cleaned
every time prior to placing the film to remove any specks of dust and the film surface
should be in contact uniformly on the flatbed to prevent the production of scanning
artefacts such as Newton’s ring (47). A scanner warm-up procedure needs to be carried
out by running the scanner several times before scanning the film to stabilise the scanner
signal.
According to Bufacchi et al., radiochromic film provides reliable dose verification
for in vivo dosimetry for TSET (34). The study was performed by using a six dual-field
16

technique and a 6 MeV electron beam and doses measured with the EBT film were
directly compared to TLDs. They concluded that the EBT film provides a good agreement
with TLD and the percentage differences between EBT film and TLD readings measured
on 20 different spots on 80 patients’ body were mostly within ± 5% (34).

2.5.3 Parallel plate ionisation chamber
The ionisation chamber is the most commonly used dosimeter in radiotherapy and
the principle of operation is well understood for clinical use. It is reliable and easy to
operate and provides accurate dose readings in real-time and therefore recognised as the
standard for calibration and used to compare with other dosimeter types (4). It has
characteristics of excellent dose linearity, directional independence (particularly to the
thimble type ionisation chamber) and almost energy independent over a wide radiation
energy range (48, 49). Most ionisation chambers use air as an active medium and
correction factors that are required to determine absorbed dose to water are well
established in ionization chamber dosimetry (4, 50). These includes perturbation factor,
chamber-dependent conversion factors for converting the air kerma (kinetic energy
released per unit mass) to absorbed dose, and atmospheric factors such as temperature,
pressure and humidity (10, 50). Calibration of ionisation chambers is performed by using
a cobalt-60 γ-ray beam either for air kerma in air, exposure, or for absorbed dose to water
at a primary standards laboratory (51). Therefore, the calibration coefficients for absolute
dosimetry are known and available to be used for clinical radiation sources (51). When
the incident photons enter the ionisation chamber, some photons interact with the air
molecules and produce secondary electrons while some photons are scattered and escape.
Secondary electrons then interact with the atoms of the air and results in ionisation and
deposition of kinetic energy. Some electrons lose energy via radiative energy loss such
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as Bremsstrahlung and characteristic x-rays. Ions produced from the ionisation are then
collected using an electric field and the charge is measured for dose reading (4). The
applied voltage (U) used for ionisation chamber is approximately 100 V to 400 V (4).
A few factors should be corrected for absolute dosimetry when using ionisation
chamber. Temperature and pressure can vary the number of air molecules in vented
ionisation chambers and the correction can be made with the formula below.
pr
T
pp,T = ( ) × ( )
p
Tr

(4)

Where pr is the reference pressure (101.3 kPa), p is the measured pressure, Tr is the
reference temperature (295.2 K or 22 °C), and T is the measured temperature (4, 52, 53).
The influence of humidity is usually negligible because all therapeutic dosimeters are
built to keep humidity well below 1 % (54). However, at higher humidity, moisture on
the surfaces can cause leakage from the chamber and electrometer. So, leakage must be
monitored when taking measurements with chambers that are built with a hygroscopic
material such as A-150 plastic or nylon (4). The effect of polarity should also be checked
because the ion charge readings could be different depending on the direction of the
voltage polarity of ionisation chamber (4). The effect is significant when the dose reading
is performed in charged particles such as electrons while the effect is very small in photon
beams (10, 50). Correction can be made by taking measurements at both polarities and
the true reading is the mean value of the absolute values of two readings (4, 10, 50). The
recombination of electrons and ions result in a loss of charge collection within the
ionisation chamber and therefore a loss of signal. This effect is significant in pulsed
radiation beams from a linac that are used in radiotherapy and can cause an effect of more
than 1% in readings, while it is almost negligible for continuous radiation beams. This
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ionic recombination effect also needs to be corrected when using an ionisation chamber
(10, 50).
Parallel plate ionisation chambers are good for surface dose measurements
because unlike thimble type chambers, they have a wide, flat entrance window and narrow
plate separation. For example, a commercially available Attix chamber has a wall
diameter of 40 mm, window thickness of 0.025 mm (4.8 mg/cm2), and plate separation
of 1 mm (4, 55). The Attix chamber is reliable for surface dose measurements and, with
the Rawlinson correction, gives a high accuracy of ± 0.5 % for 6 and 24 MV photon
beams (13, 18). Compared to other plane parallel plate ionisation chambers, it has a wide
guard ring which provides improved field homogeneity and minimises the perturbation
effect. So, it prevents the secondary electrons that are scattered from inside of the detector
side wall being counted by the collecting electrodes (4). Extrapolation chambers can also
provide accurate dose measurements at very shallow depth. However, dosimetry with the
extrapolation chamber is time consuming (56). Also, using parallel plate ionisation
chambers are clinically impractical for in vivo dosimetry due to their large size and rigid
structure (57). Furthermore, since an ionisation chamber uses high bias voltage of
approximately 100 V to 400 V, they cannot be used on patients due to safety issues.

2.5.4 Metal oxide semiconductor field effect transistor dosimeter
Metal oxide semiconductor field effect transistor (MOSFET) is a type of transistor
that amplifies or switches the electronic signals. With its small dosimetric volume, it has
advantages of immediate dose readout and permanent data storage. In 1974, Andrew
Holmes-Siedle suggested the use of MOSFET in space-charge dosimetry and, since then
it has been used as a monitor for radiation damage of spacecraft (58, 59). Space-charge
refers to the charge density that is trapped in the dielectric (insulating material) due to the
19

effect of ionising radiation. The increase of radiation induced charge density results in a
change of the dielectric surface potential which is proportional to the radiation dose (59,
60).
A MOSFET consists of a silicon substrate, three terminals; gate, source and drain
and an insulating silicon dioxide (SiO2) layer as illustrated in Figure 10. The SiO2 layer
acts as an insulator and sits in between the gate and the silicon substrate. The source and
drain sit on the silicon regions that are doped with opposite charge to the silicon substrate.
The MOSFET can be either a ‘p’ or ‘n’ channel device depending on the type of silicon
substrate. For example, an n-channel MOSFET (nMOSFET) device is made of a
positively doped silicon substrate and electrons are the charge carriers for conducting the
channel current from the source to the drain. Whereas a p-channel MOSFET (pMOSFET)
device has the n-type silicon substrate and holes are the charge carriers. The channel
region forms just under the SiO2 layer and connects the source and the drain.

Figure 10. Structure of the nMOSFET detector

A bias voltage is applied to the gate (Vg) and the conductivity of the MOSFET is
controlled by varying the gradient of Vg. Depending on the type of silicon substrate, Vg
can be either positive or negative. The MOSFET is in its off state when the Vg is at zero.
The gate voltage that is required for current to flow through the conduction channel
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between the source and the drain is known as the threshold voltage (Vth) and the MOSFET
dosimetry involves the measurement of the change in Vth (ΔVth). When irradiated,
ionising radiation causes the production of electron-hole pairs within the SiO2 layer. The
minimum energy required to produce an electron-hole pair in SiO2 is approximately 18
eV (61). For a nMOSFET detector, positive Vg induces an electric field that causes the
electrons to move towards the gate and the holes move towards the Si-SiO2 interface. The
electrons move faster, approximately four times faster than holes at room temperature,
and escape through the gate contact. Whereas holes move through the oxide and are
trapped near the Si-SiO2 interface. The trapped holes remain near the interface and buildup a positive charge layer. The conduction channel region between the source and the
drain sits directly below the Si-SiO2 interface within the silicon substrate. The trapped
charges interfere with the current flow in the channel and therefore a larger gate voltage
is needed for constant current flow between the source and drain (61). The threshold
voltage, Vth, refers to a certain amount of Vg that is required to maintain a constant current
flow through the channel and a change in Vth is proportional to the absorbed dose received
(4). Therefore, the difference in gate voltage is calculated by
∆𝑉𝑡ℎ = Vg,post − Vg,pre

(5)

where Vg,post is the gate voltage after the irradiation and Vg,pre is the one before the
irradiation. MOSFET detectors can be operated in either active mode, with the gate
voltage supply, or passive mode, without the gate voltage supply (61). The ΔVth response
of a pMOSFET in active and passive mode can be predicted by simple electrostatic
analysis with equations below.
In active mode: ∆Vth = 0.04 D t 2ox f
In passive mode: ∆Vth ~ 0.0022 D0.4 t 2ox
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(6)
(7)

where D is the dose in cGy in the oxide, tox is the thickness of oxide in µm, and f is the
fraction of generated holes that do not recombine (61-63). With the increase in positive
bias, the parameter f becomes 1 (61). However, in general, the response of pMOSFETs
are sub-linear in passive mode due to the repulsive coulomb interaction produced by the
trapped holes near the interface and the response is modelled as
∆Vth = V0 [1 − exp(−βD)]

(8)

On the other hand, the dose response in active mode is effectively linear over a wide dose
range (21). The thickness of oxide layer and the electrical field in the oxide largely affect
the response of MOSFET device (21).
A MOSFET detector is small in size so it provides a good spatial resolution and
shows very little beam attenuation that is advantageous to be used for in vivo dosimetry
(29). It also provides near real-time dose readout unlike other in vivo dosimeters such as
TLDs and films. Many studies have been performed using MOSFET detectors for in vivo
dosimetry. These include dosimetry in a total body irradiation (TBI) (64), intensity
modulated radiation therapy (IMRT) (65), serial tomotherapy (66), image guided
radiation therapy (IGRT) (67), brachytherapy (14, 61), and microbeam radiation therapy
(68).
There are factors that need to be considered when using MOSFETs for radiation
dosimetry. MOSFETs show a decrease in sensitivity with respect to the total absorbed
dose and exhibit energy dependence as they are made of silicon (4, 29). So, corrections
are necessary when using single MOSFETs (4). Their reading drifts slightly after the
exposure and therefore a consistent delay must be made when readings are taken after
each exposure (4, 37).
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MOSFETs are also temperature dependent. According to Cheung et al., the Vth of
MOSFET varies with the temperature and the level of variations is dependent on the dose
history (67). However, they also reported that this temperature dependence is almost
insignificant within the temperature range of 15 ºC to 40 ºC with variations less than 1.5 %
(67). For accurate dose measurements, the temperature effect could be resolved by using
dual MOSFET system which involves using two MOSFET detectors on the same
substrate but with different gate bias voltages (61). This system provides error reduction
by subtracting signals from each MOSFET after irradiation. Errors could also be
minimised if the voltage reading before and after irradiations were performed at the same
temperature even though the temperature during irradiation varies (67). So, when used
for in vivo dosimetry, the detector needs to be attached to the patient’s body and kept for
at least a minute to allow thermal equilibrium to occur before the initial reading. Then,
after the irradiation, post irradiation reading needs to be performed before removing the
detector from the patient (67). Alternatively, take post irradiation reading at least 2
minutes after removal from the patient to allow the detector to cool down to room
temperature if pre-irradiation reading was performed at room temperature (67).
Commercially available MOSFET detectors use an epoxy bubble as a build-up
layer and the sensitive volume of the MOSFET chip is enclosed within it. This epoxy
bubble provides approximate water equivalent depth (WED) of 0.6 to 1.8 mm which is
inappropriate for accurate skin dose measurements since the radiosensitive layer of the
skin, called basal cell layer, sits at an approximate depth of 0.07 mm (5).

2.5.5 MOSkin detector
The MOSkin detector, designed by the Centre for Medical Radiation Physics
(CMRP) at the University of Wollongong, could be an effective skin dosimeter for
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electron beam therapy. It is a MOSFET based detector and it consists of a 350 µm thick
p-type MOSFET which has a 0.55 µm thick gate oxide (57, 69). As seen in the figure 11,
the major differences between the MOSFET and MOSkin are the packaging and their
build-up layers. Within a typical MOSFET detector, the MOSFET chip sits on the surface
of the chip carrier packaging and is covered by an epoxy bubble as a build-up layer that
produces WED of approximately 0.6 to 1.8 mm. However, in MOSkin detector, the chip
is dropped below the packaging surface and is hermetically sealed by a highly
reproducible tissue equivalent build-up layer (57, 69). The build-up layer can be varied
when manufactured in order to produce a desired WED (69).

Figure 11. Comparison of packaging between (a) commercially available MOSFET detector and (b) the
MOSkin detector (reproduced from (57, 69))

Several studies have proved that the MOSkin detector is an effective dosimetric
tool for skin dose measurements. Kwan et al. performed skin dose measurements with six
individual MOSkin detectors with a 6 MV photon beam and its response about the
detector azimuth with an Ir-192 source used for HDR brachytherapy. They concluded that
the MOSkin detector provides excellent surface dose readings in a 6 MV photon beam
with angular dependence of less than 2 % and their angular response about the detector
azimuth for Ir-192 source is within 2% over all angles (69). Qi et al. reported that the
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MOSkin detector showed good agreement with the Attix chamber and EBT Gafchromic
film for the dose measurements in a 6 MV photon beam at the surface and build-up region
both perpendicularly and up to 75 degrees of obliquely incident beams (57). In 2014, Jong
et al. performed characterisation of the MOSkin detector on the phantom surface in 6 and
10 MV photon beams and proved that the MOSkin detector is suitable for surface dose
measurements (6). They stated that the MOSkin detector shows excellent dose linearity
and reproducibility, source to surface distance dependence of less than 2% over a range
of 80 to 110 cm and good agreement with the Attix chamber for angular dependence when
it is in face-up orientation (6). The maximum difference was found to be 18.5 % when
the MOSkin is in face-down orientation. Therefore, the MOSkin detector should be
positioned in face-up orientation when it is used for skin dosimetry (6). The angular
dependence of MOSkin detector may be different for electron beams due to the different
interaction process and energies.
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3. MATERIALS AND METHODS
3.1 Linear accelerator
All measurements were performed with an Elekta Infinity linear accelerator
(Elekta AB, Stockholm, Sweden), shown in Figure 12, at the Department of Radiation
Oncology at the Prince of Wales Hospital.

Figure 12. Elekta Infinity linear accelerator at the Department of Radiation Oncology at the Prince of Wales
Hospital

Measurements for calibration, dose linearity, percentage depth dose and angular
response were performed with a 10 cm x 10 cm electron applicator. A 40 cm x 40 cm
‘applicator’ was used for the TSET measurements although this was merely a type of
physical interlock to allow the machine to set a 40 cm x 40 cm field size defined by the
secondary collimator jaws which is not allowed for normal electron beams for treatment
at isocentre. The nominal output of the 6 MeV electron beam of this linear accelerator
was calibrated with a traceable (to a secondary standards laboratory) ionisation chamber
to deliver 1 cGy per monitor unit (MU) at dmax of 13 mm in water. A MU is a defined as
a unit of measure of the dose output by the accelerator measured by a pair of ionisation
chambers located below the radiation source (the target or the electron scattering foils)
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within the linac treatment head (4). For any exposure, the linear accelerator is
programmed to deliver a certain amount of monitor units which the ionisation chambers
detect and shut off the beam when the programmed monitor units are delivered.

3.2 Phantoms
Various thicknesses of 30 cm x 30 cm sized Solid Water phantoms (Gammex RMI,
Middleton, WI, USA) and a Plastic Water phantom (Computerized Imaging Reference
Systems Inc., Norfolk, VA, USA) that has a shallow groove, approximate depth of 0.5
mm, for the MOSkin were used for characterisation of the MOSkin detectors at different
depths. For TSET measurements, a cylindrical Perspex phantom (length = 18.5 cm,
diameter = 18 cm) (Lucite International, Southampton, UK) was used with three different
types of detectors (Gafchromic EBT3 film, TLD, and MOSkin). A 6 mm Perspex spoiler
sheet with a dedicated wooden frame were used and placed in front of the rotating
platform (a distance of 85 cm from the axis of rotation as was used clinically).

Figure 13. A cylindrical phantom (left) and the setup (right) used for TSET measurements
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3.3 MOSkin detector
The Centre for Medical Radiation Physics (CMRP) designed MOSkin detector
and its electrometer for the gate threshold voltage reading are shown in Figure 14 and 15.

Figure 14. MOSkin dosimeter developed by the Centre for Medical Radiation Physics (CMRP) at the
University of Wollongong. (a) Connector pin end, (b) MOSkin sensor end (face down), (c) MOSkin sensor
end (face up)

The MOSkin detector with the connecting cable strip used in these experiments
was 33 cm long, 3 mm wide, and approximately 0.5 mm thick externally. The MOSkin
detector was connected to the CMRP designed Clinical Semiconductor Dosimetry System
(CSDS) via a cable for dose reading. CSDS is a battery powered electrometer that can
read the gate threshold voltages of up to five MOSkin detectors simultaneously. The
readout was performed each time before and after the irradiation by pushing the
MANUAL READ button on the CSDS. As mentioned in Chapter 2.5.4, MOSFET reading
drifts slightly after the exposure. So, a consistent delay of 30 seconds was taken each time
after the irradiation before reading the gate voltage.
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Figure 15. Clinical Semiconductor Dosimetry System developed by the Centre for Medical Radiation
Physics (CMRP). A MOSkin detector is connected via a cable.

3.4 Thermoluminescent dosimeters
For calibration, eight TLD-100 chips (3.2 mm x 3.2 mm x 0.9 mm) (HarshawBicron, Solon, OH, USA) were placed within a calibration tray which arranges the TLDs
in a circle equidistant from central axis of the radiation beam. Calibration was performed
using a 6 MeV electron beam with the standards at the depth of maximum dose, dmax of
1.3 cm in a Solid Water phantom using a 10 cm x 10 cm applicator. The expected accuracy
estimated from the calibration data was within ± 1.9 %. For TSET measurements, pairs
of different but same sized TLD-100 chips (with known dose sensitivity) were packed by
using small paper snips, a thin plastic foil and sticky tape as shown in Figure 16. TLDs
must be handled with care because scratches or contamination of the surface of the
material could reduce the emission of the light from the material. (4) TLD annealing and
dose reading procedures were performed according to the Prince of Wales Hospital
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Radiation Oncology Medical Physics departmental protocols. These protocols date back
to work done by Amies et al. (70). A RadPro oven (RadPro international GmbH,
Wermelskirchen, Germany) was used for pre-read (100 °C for fifteen minutes) and postread (400 °C for an hour) annealing process and the Harshaw-Bicron 5500 Automatic
TLD Reader and WinREMS software (Harshaw-Bicron, Solon, OH, USA) were used for
TLD readings.

Figure 16. TLD packaging for in vivo dosimetry (reproduced from (4))

3.5 Radiochromic film
Gafchromic EBT3 films (Ashland Specialty Ingredients, Wayne, NJ, USA) with
dimensions 5 cm x 5 cm were prepared. For calibration purpose, 8 pieces of film were
irradiated at dmax of 1.3 cm using 6 MeV electron beam under conditions of 100 cm SSD,
10 x 10 cm2 field size to different doses of 0, 20, 60, 100, 140, 180, 220, and 260 cGy.
For total skin electron therapy (TSET) skin dose measurements, thin plastic foil (cling
wrap) was used to cover the EBT3 films to protect the film surface when attaching onto
the cylindrical phantom. The Epson 10000XL Photo flatbed colour scanner (Epson
America Inc., Long Beach, CA, USA) was used for pre- and post-irradiation scans. For
scanning, the plastic foil was removed from the film and surface marks left on the film
surface was negligible. A warm-up procedure was carried out and the scanner’s flatbed
surface was cleaned before scanning films. Every film was scanned with the same
30

orientation to minimise polarisation effect. Calibration and the dose readings were
performed by using in-house software developed by Dean Inwood, a Radiation Oncology
Medical Physicist at the Prince of Wales Hospital.
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Figure 17. Gafchromic EBT3 film calibration curve

Figure 17 shows the calibration curves for red, green, and blue channels. Each
curve is fitted with a third order polynomial and shows the fit of the regression line. It
appears that the red channel has a higher response than other channels up to 260 cGy.
Therefore, due to the higher sensitivity and greater degrees of the calibration curve, the
dose was read from the red channel.

3.6 Calibration, dose linearity and lifetime of MOSkin detector
Measurements of calibration, dose linearity, percentage depth dose and angular
response of the MOSkin for 6 MeV electron beam were performed with a 10 cm x 10 cm
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electron applicator. A MOSkin was calibrated at the central axis of the 6 MeV electron
beam at the depth of 1.3 cm (dmax) in 30 cm x 30 cm Solid Water, 10 cm backscatter, 100
cm source to surface distance (SSD), and 10 x 10 cm2 field size. The linearity of the
detector was tested within the dose range of 2 to 8 Gy with an increment of 2 Gy and
reproducibility was determined from the average standard deviation of three repeated
measurements at each dose level. The MOSkin was irradiated with the face-up orientation
(as appeared on Figure 14(c)).

Figure 18. Setup for MOSkin calibration and dose response at depth of 1.3 cm

A new, non-used, MOSkin detector was used to verify changes in sensitivity as a
function of accumulated dose throughout its lifetime. For this measurement, the doses of
200 cGy were constantly delivered per beam until the gate threshold voltage of the
MOSkin detector reached the maximum and become unable to provide a dose reading.
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Changes in the gate threshold voltage of the MOSkin detector were recorded for each
beam and the sensitivity of the detector was calculated for the accumulated dose.

3.7 Percentage depth dose measurement
Percentage depth dose (PDD) curves of the 6 MeV electron beam were obtained
with both a MOSkin detector and a PTW Roos parallel plate chamber (PTWFreiburg GmbH, Freiburg, Germany). The Roos electron chamber is regarded as a
reference class electron chamber and is recommended for precise dosimetry of high
energy electron beams (68, 71). It has the inherent build-up of 1.3 mm and the effective
point of measurement is at 1.12 mm depth from the surface (71). The depth ionisation
distribution measured with Roos chamber were converted to depth dose distribution by
multiplying the charge at each depth by the stopping power ratio (sw,air) of the same depth
in accordance with the IAEA TRS-398 for the electron beam energy (50). The MOSkin
detector was embedded onto the slit of this phantom in a face-up orientation and
connected to the electrometer via a cable. The readout was performed each time before
and 30 seconds after the irradiation to stabilise the gate voltage reading. Percentage depth
dose measurements were performed under the conditions of 10 x 10 cm2 field size, and
10 cm backscatter. Note that the PDD measured for testing the MOSkin was not
performed at the TSET conditions but instead at 100 cm SSD for convenience. For PDD,
doses were delivered 50 MU per beam for the range of depth from the surface to 25 mm
and 200 MU for the depth at 30 mm.
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3.8 Angular response
Measurements were performed for the response of the MOSkin and Gafchromic
EBT3 film with respect to incident beam angle on the surface and at 1 mm depth of 30
cm x 30 cm sized Solid Water phantom for 6 MeV electron beam. The dose was delivered
at gantry angles of 0, 15, 30, 45 and 60 degrees under the conditions of 100 MU per beam,
10 cm x 10 cm field, SSD 100 cm. The same MOSkin used for PDD measurement was
used for this measurement. For film dosimetry, mean optical density was calculated from
the centre of each film and the region of interest was 2 x 2 cm in size. The dose response
curves were produced 24 hours after the irradiation and fitted with a third order
polynomial.

Figure 19. Setup for MOSkin angular response
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3.9 Dose rate dependence
According to Di Martino, F., et al., a parallel-plate ionisation chamber is
recommended for measuring accurate absorbed dose in pulsed high energy electron
beams (72). Electron beams that are used in radiotherapy are pulsed beams and typically
have less than 0.1 cGy of dose per pulse (72). Within this range, it is recommended that
a correction factor k s be evaluated by using the two-voltage method to correct the
incomplete charge collection response of an ionisation chamber caused by the ion
recombination (10, 50, 73). The incomplete charge collection in an ionisation chamber
depends on the dose rate (10, 50). The ion recombination factor k s can be found from the
equation below.

k s = a 0 + a1 (

M1
M1 2
) + a2 ( )
M2
M2

(9)

Where ax are coefficients for the calculation of k s by the two-voltage method as a
function of the voltage ratio V1/V2 (10, 50, 74). The polarising voltage V1 is the voltage
normally used for operating the ionisation chamber and V2 is the voltage lower than V1.
M1 and M2 are charges collected at V1 and V2 respectively. In this experiment, the Roos
chamber was used and charges were collected at 300 V (V1) and 100 V (V2). So, for the
voltage ratio (V1/V2) of 3, coefficients used for ks calculation were a0 = 1.198, a1 = -0.875,
and a2 = 0.677 (10, 50).
Both the Roos chamber and MOSkin were measured for the 6 MeV electron beam
at dmax of 1.3 cm at the different source to surface distances (SSD) from 100 cm to 146
cm with 10 cm increments. Measurements were repeated twice at each SSD point and
100 MU were delivered for each beam.
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3.10 Total skin electron therapy (TSET) measurement
All three different types of detectors (Gafchromic EBT3 film, TLD, and MOSkin)
were calibrated for 6 MeV electron beam under the conditions of 1.3 cm depth (dmax) in
30 cm x 30 cm solid water, 5 cm backscatter, 100 cm SSD, and 10 x 10 cm2 field size and
sensitivities were calculated before the TSET measurement. For TSET measurement, an
18 cm diameter cylindrical phantom and a rotating platform were used and detectors were
placed on the surface of the cylindrical phantom; TLDs placed 3 cm above and MOSkin
detectors placed 3 cm below from the centre of Gafchromic EBT3 films, as shown on
figure 20, for a direct comparison of measured dose. These detectors were then covered
by a 1 mm of the tissue equivalent plastic sheet for build-up to measure the skin dose at
the prescription depth of 1 mm (21).

Figure 20. Three different types of dosimeters used for TSET measurement. TLD packet (top), 3 pieces of
Gafchromic EBT3 films (middle), 3 MOSkin detectors (bottom)

Measurements were performed using a 6 MeV high dose rate electron (HDRE)
beam under the clinical treatment conditions of 350 cm SAD (source to rotation axis
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distance), 1mm build-up layer (prescription depth), 40 x 40 cm2 field size. The eight static
dual-field technique was chosen for the experimental measurements, instead of the
rotational technique because, just like the MOSFET, the MOSkin needed a cable for
external gate voltage supply to keep stable detector sensitivity. The nominal patient
diameter is approximately 30 cm and therefore the measurements were taken at the SSD
(source to surface distance) of 335 cm. TSET dose was delivered in two fields using
gantry angle of 252° (superior field) and 288° (inferior field) and measurements were
taken at different heights; 20 cm, 55 cm, 90 cm, 130 cm, 170 cm from the rotating
platform. A modified Stanford irradiation technique (8 static dual fields) was used and
the TSET dose was delivered in 8 directions per field (anterior, posterior, right lateral,
left lateral, right anterior oblique, left anterior oblique, right posterior oblique and left
posterior oblique as appeared on Figure 9 in Chapter 2).

Figure 21. Geometrical setup of dual field (superior and inferior) technique.

Currently, at Prince of Wales Hospital, the linac is calibrated under TSET
treatment conditions of 335 SSD, 350 SAD, 1 mm prescription depth, 40 x 40 cm2 field,
866 monitor units (MU) per field and 310 MU/min dose rate to provide average surface
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dose of 222.8 cGy across a total combined beam junction of superior and inferior beams
using a rotational technique. A 6 mm Perspex spoiler is placed at the same distance as
used clinically and aligned perpendicularly to the beam to lower the effective beam
energy and increase the surface dose.
For these experiments, the prescribed skin dose at 1 mm depth was chosen to be
200 cGy. The PDD curve of 6 MeV HDR electron beam under TSET treatment conditions
of a rotating patient with a 6 mm spoiler is shown in figure 22. This graph is used for
calculating required MU for each treatment fraction at Prince of Wales Hospital if the
depth of prescription was not at the surface. The R50 (the depth where the absorbed dose
falls to 50% of the maximum dose) estimated from this data is approximately 12.3 mm
and the mean surface energy calculated by using the equation (2) is approximately 2.9
MeV.
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Figure 22. Prince of Wales Hospital PDD Data, HDRE TSET conditions with 6 mm spoiler
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In the case of these experiments, the dose was prescribed to 1 mm depth. So, for
prescription dose of 200 cGy at the prescription depth of 1mm
Percentage depth dose (PDD) = 100 %
Prescribed surface dose = 200 / 1.00
= 200 cGy
And the required monitor unit for TSET is calculated by
Required MU =

=

Calibrated MU per field ×Prescribed surface dose
Calibration dose

(10)

866 MU × 200 cGy
222.8 cGy

= 777.4 MU per field
This 777.4 MU would normally be prescribed as a rotational delivery where the patient
would undergo 7 complete rotations during each 777.4 MU exposure. An assumption was
made that the 777.4 MU exposure would give the same approximate dose to the phantom
if the MU were equally divided across the eight fields. That is, 97.2 MU per patient
orientation (see figure 9 in chapter 2). This assumption can be made since the significance
of the results is the comparison of the dose measured by the MOSFETs compared to the
TLDs and Gafchromic EBT3 film and not the absolute dose delivered.
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4. RESULTS AND DISCUSSIONS
4.1 Calibration, dose linearity and lifetime of MOSkin detector
The MOSkin detector was calibrated and the average sensitivity was calculated as
2.392 ± 0.027 mV/cGy for this study. MOSkin dose response was observed to be
effectively linear (R2 = 0.9986) over 3 Gy of total dose.
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Figure 23. Dose linearity of the MOSkin detector

The maximum difference from the linear curve was found to be 8.1 % at the dose
of 5 cGy. It is noticeable that the difference in gate threshold voltage response decreases
with the cumulative dose. Studies have found that, in x-ray photon beams, the sensitivity
of the MOSFET detector decreases by 0.09 mV/cGy for every 10 Gy of accumulated dose
(6, 75). The dose response of the MOSkin detector is effectively linear until the gate
threshold voltage reaches approximately 24 V (76).
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Figure 24. MOSkin detector response throughout its lifetime

Measurements were taken throughout the lifetime of the MOSkin detector with 6
MeV electron beams. In general, similar to its behaviour in photon beams, the sensitivity
of the MOSkin detector decreases as a function of the accumulated dose. According to
Jong et al., the sensitivity of the MOSkin decreases with accumulated dose by
approximately 0.4 % for every 100 cGy for 6 MV photon beam (6).
The changes in sensitivity are effectively linear between the accumulated doses
of 1000 cGy and 7800 cGy. The gate threshold voltage reading at the accumulated dose
of 1000 cGy was 11.657 V and at the accumulated dose of 7800 cGy was 25.853 V.
Initially, the calculated sensitivity was 2.445 mV/cGy at the accumulated dose of 200
cGy and 1.91 mV/cGy at the accumulated dose of 7800 cGy. This indicates that the
sensitivity of the MOSkin detector decreases by 6 x 10-3 mV/cGy (approximately 0.3 %
changes) for every 100 cGy. The mean sensitivity was 2.142 mV/cGy. The maximum
gate threshold voltage of the MOSkin detector was recorded 26.974 V. Changes in
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sensitivity are effectively linear and the changes in percentage are very low. So, the
MOSkin detector can provide acceptable dose readings until the gate threshold voltage
reading reaches approximately 26 V. With this data, the MOSkin sensitivity at each
measurement will be known from the accumulated dose. However, recalibration of the
MOSkin detector must be carried out regularly to be able to obtain accurate dose readings.

4.2 Percentage depth dose measurement
The response of the MOSkin was similar to the Roos chamber within the build-up
region and at dmax although 1.7 % of difference was measured at 1mm depth. In the dose
fall-off region, the estimated R50 measured with MOSkin is 25.29 ± 0.14 mm while 24.80
± 0.014 mm with the Roos chamber which is approximately 0.49 ± 0.15 mm difference
in depth. So, the MOSkin tends to overestimate the R50 when compared to the Roos
chamber. The uncertainties of both detector types were estimated based on the average
standard deviation of three repeated measurements at each depth. The Range of error in
the R50 were estimated by interpolating the larger and smaller errors in each point
measurements along the PDD curves of both detectors, so that the depths where these
cross the 50% of the maximum dose were the uncertainties in the R50.
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Figure 25. Percentage depth dose data of 6 MeV electron beam measured with MOSkin and Roos
chamber

The MOSkin is a MOSFET based detector and its sensitive volume is made of
silicon. Therefore, it exhibits little energy dependence. According to the ESTAR stopping
power and range tables for electrons provided by the National Institute of Standards and
Technology, USA (NIST), the total stopping power for a 6 MeV electron for Silicon is
1.813 MeV cm2/g whereas 2.010 MeV cm2/g for water, 1.995 MeV cm2/g for soft tissue,
1.982 MeV cm2/g for skin and 1.937 MeV cm2/g for Perspex (77). So, it tends to under
respond for higher energies at shallow depths and over respond for lower energy at deeper
depths when compared to ionisation chamber (78, 79). With the R50 measured from the
PDD data, the mean surface energy could be calculated by using the equation (2) as
mentioned in Chapter 2.4.
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4.3 Angular response
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Figure 26. Angular response of MOSkin detector and Gafchromic EBT3 film

Figure 26 shows the angular response of MOSkin and Gafchromic EBT3 film that
have been normalised to the incident angle of 0 degree. The uncertainties of both detector
types were estimated based on the average standard deviation of two repeated
measurements at each angle. In general, it appears that the dose measured with both
dosimeters increases gradually as the incident beam angle increases. This is because the
charged particle equilibrium (CPE) region moves towards the phantom surface as the
beam angle increases (6). The CPE exists where the number of charged particles entering
is equal to the leaving and the dose is equal to the collisional kerma (4). A fraction of
incident electrons undergo radiative energy loss including Bremsstrahlung production
within the phantom and thus the deposited dose is equal to the collisional kerma but
smaller than kerma (4). Doses were measured higher with EBT3 film than the MOSkin
on the surface. This may be due to the difference in thickness of built-in water equivalent
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layer as water equivalent depth (WED) of the MOSkin detector is approximately 0.07 mm
while WED of EBT3 film is approximately 125 µm (42). According to Suchowerska et
al., radiochromic film is nearly angular independent (80) and, as shown above, the
MOSkin detector behaves very similarly to the Gafchromic EBT3 film. Experimental
random errors might be present when handling and/or taking measurements with
Gafchromic EBT3 film as differences appeared at 1 mm depth at the gantry angle of 30
degrees (5.9 % difference) and on the surface at 60 degrees (4.7 % difference). The
expected accuracy estimated from the calibration data was within ± 0.8 %.

4.4 Dose rate dependence
The graph below illustrates the dose responses of Roos chamber and MOSkin
detector at different SSD.
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Figure 27. Dose per pulse for 6 MeV electron beam measured with Roos chamber and MOSkin detector at
dmax
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Data for the Roos chamber were corrected for ion recombination and all measured
doses were normalised to the meter reading at 100 cm SSD. As the graph illustrates, the
Roos chamber and MOSkin show similar response with less than 1% difference over 100
cm to 140 cm SSD. This result indicates that MOSkin is almost dose rate independent
over 100 cm to 140 cm SSD for 6 MeV pulsed electron beam. The maximum percentage
difference of 1.5 % was found at SSD of 146 cm.

4.5 TSET measurement
Before the TSET measurements, three MOSkin detectors were calibrated and
calculated sensitivities of MOSkin #1, 2 and 3 were 2.417 ± 0.014 mV/cGy, 2.4 ± 0.025
mV/cGy, and 2.458 ± 0.038 mV/cGy respectively.
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Figure 28. TSET dose at different heights from the rotating platform
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The graph above shows the measured doses with MOSkin, TLDs, and Gafchromic
EBT3 films at different heights above the rotating platform under clinical TSET condition.
In general, all three detector types showed a very similar trend of dose readings over every
measurement points. Except for the dose readings with ‘MOSkin #3’ at 87 cm and 127
cm, all MOSkin dose readings are within the ranges of the other two dosimeters at all
measured points. So, this proves that the MOSkin provides stable skin dose readings for
TSET dosimetry that compared acceptably with the TLD and Gafchromic EBT3 film.
The combined field is determined by two overlapping beams, one of which may have
additional scatter from the floor or the base of the Perspex screen and the rotating platform.
This might be the reason for the higher dose readings at 20 cm and 55 cm. The measured
doses at 90 cm indicates the junction of superior and inferior treatment fields while the
doses at 55 cm and 130 cm indicate the central axis of each treatment field. The maximum
percentage difference calculated between TLD readings and the average MOSkin
readings were 8.2% at 52 cm and 4.5 % at 87 cm. TSET measurement was performed
once only and the uncertainties of TLD and film readings were estimated based on the
average standard deviation of two TL crystals and three films at each measurement point.
Random errors might be present within the dose readings particularly at 20 cm and 55 cm.
The possible source of errors might be present when preparing TLD patches and wrapping
films individually. Marks presented on the film surfaces after removing thin plastic foils
for dose analysis might also affect the dose readings.
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5. CONCLUSIONS AND FUTURE DEVELOPMENTS
Characteristics of the MOSkin detector for a 6 MeV electron beam showed that it
behaves very similar to the other types of dosimeters that are commonly used in vivo
dosimetry. The MOSkin detector showed an effectively linear dose response. Although
the sensitivity of the MOSkin detector decreases as a function of the accumulated dose,
the trend was still very similar to its behaviour in photon beams. The changes in
sensitivity are effectively linear between the accumulated doses of 1000 cGy and 7800
cGy and proved that it provides acceptable dose readings until the gate threshold voltage
reading reaches approximately 26 V. The PDD data showed that the MOSkin responses
similarly to the Roos chamber within the build-up region and at dmax for a 6 MeV electron
beam. It also behaved similarly to Gafchromic EBT3 film when surface doses were
measured at different incident beam angles. The MOSkin detector is almost dose rate
independent over 140 cm SSD for 6 MeV pulsed electron beam although the maximum
percentage difference of 1.5 % was found at SSD of 146 cm. For TSET dosimetry, it
provided stable skin dose readings that compared acceptably with the TLD and EBT3
film results. Therefore, the MOSkin detector is an effective skin dosimeter for TSET
dosimetry and it could be an alternative for in vivo skin dosimetry during electron beam
therapy.
For future developments of a MOSkin detector system for in vivo TSET
measurements, the application of a wireless system for MOSkins could be a huge
advantage in a clinical environment, particularly as the skin doses need to be measured
from 30 different spots on patient’s body. For keeping high and stable detector sensitivity,
the MOSkin needs to be operated in active mode (with the external gate voltage supply)
and a cable needs to be connected while operating. So, an external gate voltage supplying
electrometer that is mobile and can be kept within the treatment room is necessary to be
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used in a clinical environment. CMRP developed a wireless electrometer system for the
MOSkin detector, called OneTouch MOSkinTM appeared on figure 29. It is mobile (battery
operated), small, and light. So, by placing it on the top of the treatment frame or on the
rotating platform, the TSET could be performed by using either rotational or static
irradiation techniques while operating the MOSkin detectors in active mode. A new
design that can operate multiple MOSkin detectors (up to 30) to be operated
simultaneously is needed as the current model allows only up to 6 MOSkin detectors.

Figure 29. OneTouch MOSkinTM; CMRP designed wireless electrometer for MOSkin detector
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